NasdaqHealth CareSurgical & Medical Instruments & ApparatusLANGHORNE, PA

NexGel, Inc NXGL

Ask your AI

Estimated market cap $1.89M487,383 shares, shares as of Aug 14, 2026CIK 1468929

Insider trades, 12 mo

2 buys · 11 sells

$36.7K sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q2 2026

9.0% of shares · 1 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q2 2026

What changed in NexGel, Inc's latest quarterly report, compared with the one before.

Filed Aug 17, 2026 · Quarter ended Jun 30, 2026

Compared with the 10-Q for the quarter ended Mar 31, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in NexGel, Inc's latest quarterly report, compared with the one before.

Loading…

Insider trades

13 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Recent insider trades

Brian Joseph Kieser Interim CEO, Director, 10% owner	Nov 10 Form 4 ↗	Buy	+$732.7K 133,216 sh @ $5.50	+7.8%
Steven Mark Glassman Director	Nov 10 Form 4 ↗	Buy	+$25.0K 4,546 sh @ $5.50	+7.8%
Adam R. Levy Chief Executive Officer, Director	Jun 23 Form 4 ↗	Sale	−$2,950 5,000 sh @ $0.59	-68.1%
Adam R. Levy Chief Executive Officer, Director	Jun 18 Form 4 ↗	Sale	−$3,540 6,000 sh @ $0.59	-66.7%
Adam R. Levy Chief Executive Officer, Director	Jun 11 Form 4 ↗	Sale	−$1,830 3,000 sh @ $0.61	-69.4%

All NXGL insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

873,361 shares

6 funds report NXGL. Values checked against market prices.

Reports for the quarter ending Sep 30, 2026 are still coming in (2 positions so far, against 6 the quarter before), so we compare the two complete quarters before it.

Q2 2026. 1 new, 1 added to, 2 trimmed, 0 exited since Q1 2026.

Top 13F holders
#
1	Armistice Capital, LLC 13F ↗	550,000	$21.2K	unchanged
2	Warberg Asset Management LLC 13F ↗	145,591	$4,746	-0.3%
3	Empery Asset Management, LP 13F ↗	90,000	$3,474	unchanged
4	Clear Street Group Inc. 13F ↗	50,814	$1,961	+0.4%
5	Two Sigma Securities, LLC 13F ↗	21,875	$584	New
6	UBS Group AG 13F ↗	15,081	$407	-6.2%

Download CSV Every fund that holds NXGL, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What NexGel, Inc and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What NexGel, Inc and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q4 2021	4	—	424,300	$357.0K
Q1 2022	6	+2	984,127	$425.0K
Q2 2022	5	-1	981,000	$274.0K
Q3 2022	7	+2	985,377	$296.0K
Q4 2022	6	-1	894,997	$134.5K
Q1 2023	7	+1	1.02M	$184.8K
Q2 2023	5	-2	888,614	$386.4K
Q3 2023	4	-1	838,514	$284.7K
Q4 2023	3	-1	828,214	$405.8K
Q1 2024	3	0	828,114	$596.2K
Q2 2024	4	+1	828,184	$361.9K
Q3 2024	3	-1	826,114	$355.4K
Q4 2024	3	0	807,100	$605.3K
Q1 2025	5	+2	814,602	$359.2K
Q2 2025	4	-1	786,649	$196.7K
Q3 2025	4	0	767,913	$230.3K
Q4 2025	6	+2	838,014	$197.5K
Q1 2026	5	-1	852,786	$49.7K
Q2 2026	6	+1	873,361	$32.4K
Q3 2026	2	-4	160,672	$2,190

Each point is a quarter-end, from Q4 2021 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (65344E115). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q4 2021) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes2 in 12 mo 8-K events6 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesForm 144 · 4 in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record IPO history4 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: NEXGEL, INC.
Address: 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA 19047
Phone: 215 702-8550
Fiscal year ends: Dec 31
Filer category: emerging growth company
Incorporated in: DE
Listed as: NXGL (Nasdaq), NXGLW (Nasdaq)
Former names: NEXGEL, INC. (until 2026); AquaMed Technologies, Inc. (until 2019)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$3.88+$0.09 (+2.37%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $3.51 · High $5.80Nov 13, 2026

Aug 13, 2026Low $3.00 · High $11.30Nov 13, 2026

Nov 13, 2025Low $3.00 · High $38.20Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. The stock split 1-for-20 on Oct 12, 2026; earlier prices are shown divided by the split ratio. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.